NAUTILUS BIOTECHNOLOGY, INC. (NAUT) Operating cash flow 2020–2025
NAUTILUS BIOTECHNOLOGY, INC. (NAUT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$50.7MFY2025 · since FY2020: -$14.0M → -$50.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.7M | +14.3% |
| FY2024 | -$59.1M | -14.4% |
| FY2023 | -$51.7M | -12.9% |
| FY2022 | -$45.8M | -16.7% |
| FY2021 | -$39.2M | -180.4% |
| FY2020 | -$14.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NAUT financial trends
NAUT RevenueNAUT Net incomeNAUT Net marginNAUT Gross profitNAUT Gross marginNAUT Operating incomeNAUT Operating marginNAUT Free cash flowNAUT Capital expendituresNAUT Return on equityNAUT Stock buybacksNAUT Dividends paidNAUT Total assetsNAUT Total liabilitiesNAUT Shareholders’ equityNAUT overview →